Document is current
Any future updates will be listed below
-
Authors
Myers, Lara M.
Tal, Michal Caspi https://orcid.org/0000-0003-2550-6246
Torrez Dulgeroff, Laughing Bear
Carmody, Aaron B.
Messer, Ronald J.
Gulati, Gunsagar
Yiu, Ying Ying
Staron, Matthew M.
Angel, Cesar Lopez
Sinha, Rahul
Markovic, Maxim
Pham, Edward A.
Fram, Benjamin
Ahmed, Aijaz
Newman, Aaron M. https://orcid.org/0000-0002-1857-8172
Glenn, Jeffrey S.
Davis, Mark M. https://orcid.org/0000-0001-6868-657X
Kaech, Susan M.
Weissman, Irving L. https://orcid.org/0000-0002-9077-7467
Hasenkrug, Kim J. https://orcid.org/0000-0001-8523-4911
- License Information
-
More Information
Article History
Received: 18 April 2018
Accepted: 9 January 2019
First Online: 15 February 2019
Competing interests
: I.L.W. is Co-founder, director, stockholder, and consultant at Forty Seven, Inc, a company carrying out research and clinical trials in the CD47:Sirp.alpha axis between cancer and pathological cells and body macrophages. The remaining authors declare no competing interests.
